NewcelX Ltd. ("NewcelX" or the "Company") completed the previously announced merger transaction, pursuant to that certain ...
NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a Swiss clinical-stage biopharmaceutical company developing ...
The latest update is out from NLS Pharmaceutics ( (NLSP) ).
TipRanks on MSN
NLS Pharmaceutics Expands CNS Pipeline with AEX-6xx Series
NLS Pharmaceutics ( ($NLSP) ) has shared an announcement. On October 30, 2025, NLS Pharmaceutics announced the expansion of its DOXA platform with ...
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company") and Kadimastem Ltd. (TASE: KDST) ("Kadimastem") today ...
The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...
NLS Pharmaceutics announced it entered into a definitive merger agreement with Kadimastem. One goal of the combined company is to advance NLS's Dual Orexin Agonist platform. See how Matt Maley is ...
TipRanks on MSN
NLS Pharmaceutics and Kadimastem Finalize Merger Conditions
Detailed price information for Nls Pharmaceutics Ltd (NLSP-Q) from The Globe and Mail including charting and trades.
ZURICH, SWITZERLAND / ACCESSWIRE / April 25, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback